| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 10.09. | Lonza to Add Commercial Spray-Drying Facility in Oregon | ||
| 10.09. | Retension Pharma Welcomes Two to Its Executive Team | ||
| 10.09. | VVMF Sydney Facility Gets Therapeutic Goods Manufacturing License | ||
| 10.09. | Glenmark, South Piedmont Launch Pharma Training Facility | ||
| 10.09. | Ritedose Names Carolyn Berg VP of Strategic Growth | ||
| 10.09. | CordenPharma Expands Injectable Manufacturing in Italy | ||
| 09.09. | 1cBio, Lee's Pharm Ink License Agreement for PARP1 Inhibitor in China, Southeast Asia | ||
| 09.09. | Systech Launches Intelligent Enterprise Traceability Platform | ||
| 09.09. | Matica Bio, Bondwell Partner on Texas Biotech | ||
| 09.09. | Schreiner MediPharm Labels Cut Oxygen Ingress in COC Syringes | ||
| 09.09. | Transcenta, WuXi Biologics Sign HiCB Licensing Deal | ||
| 08.09. | HeartBeat.bio, Cubase Bio Partner on Spatial Profiling for Cardiovascular Drug Discovery | ||
| 08.09. | Neurizon to Welcome Chris Bremer as CEO | ||
| 08.09. | Gilead Opens 182,000-Square-Foot Research Center in Foster City | ||
| 08.09. | Prilenia Taps Rick Munschauer as New Chief Medical Officer | ||
| 08.09. | Northway Biotech Opens €61M Cell Therapy CDMO Facility in Vilnius | ||
| 08.09. | Transgene, ProBioGen Broaden Viral Vector Partnership | ||
| 08.09. | Charles River Launches Automated Endosafe Manufacturing Suite | ||
| 08.09. | Hovione Names Stefan Doboczky as CEO | ||
| 04.09. | AtomVie Opens State-of-the-Art Radiomanufacturing Facility in Hamilton, ON | ||
| 04.09. | Hutchmed, GSK Ink $1.3B Cancer Drug Deal | ||
| 03.09. | Cipla, Qilu Enter Licensing and Supply Deal for Keytruda Biosimilar in US | ||
| 03.09. | Genprex Selects Andelyn Biosciences to Scale Manufacturing for Diabetes Gene Therapy Program | ||
| 03.09. | Curia Opens Expanded New Mexico Manufacturing Campus | ||
| 03.09. | PerkinElmer Completes SimoTech Acquisition |